asa guidelines for glp 1 drugs Anesthetic Considerations Patients Taking Glucagon-Like Peptide-1 Agonists Holding GLP-1 Agonists Prior to
Description
During this compensatory process, the expression of the GLUT1 glucose transporter protein, which is a glycolytic intermediate, is upregulated (62)
1.4% with dulaglutide and 0.3% with placebo and a bodyweight reduction of up to 16.9% with retatrutide vs
GLP-1's improvement of learning and memory can be blocked by pretreatment with exendin (939), and is absent in mice deficient for the GLP-1 receptor [417]
Only peer-reviewed scientific journals were considered during the process
